|
PSMA4 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.917170E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.063200E-01 |
| Normal-vs-Stage2 |
1.672780E-01 |
| Normal-vs-Stage3 |
1.683570E-01 |
| Normal-vs-Stage4 |
8.079600E-03 |
| Stage1-vs-Stage2 |
2.191400E-01 |
| Stage1-vs-Stage3 |
2.881400E-01 |
| Stage1-vs-Stage4 |
8.356900E-03 |
| Stage2-vs-Stage3 |
6.913400E-01 |
| Stage2-vs-Stage4 |
3.491800E-01 |
| Stage3-vs-Stage4 |
8.203600E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.093400E-01 |
| Normal-vs-AfricanAmerican |
6.091600E-02 |
| Normal-vs-Asian |
8.055400E-01 |
| Caucasian-vs-AfricanAmerican |
2.330200E-01 |
| Caucasian-vs-Asian |
3.947800E-01 |
| AfricanAmerican-vs-Asian |
1.381210E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.212570E-01 |
| Normal-vs-Female |
2.618800E-01 |
| Male-vs-Female |
3.767000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.487400E-01 |
| Normal-vs-Age(41-60Yrs) |
5.989900E-02 |
| Normal-vs-Age(61-80Yrs) |
8.799600E-02 |
| Normal-vs-Age(81-100Yrs) |
6.797400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.535800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.862400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.268400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.526600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.967600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.545000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.142600E-01 |
| Classical-VS-Follicular |
1.253620E-01 |
| Classical-VS-Other |
3.499200E-01 |
| Classical-VS-Normal |
3.103800E-01 |
| Tall-VS-Follicular |
2.860800E-01 |
| Tall-VS-Other |
5.108200E-01 |
| Tall-VS-Normal |
3.346800E-01 |
| Follicular-VS-Other |
8.509600E-01 |
| Follicular-VS-Normal |
5.481800E-02 |
| Other-VS-Normal |
2.226800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.671800E-01 |
| Normal-vs-N1 |
9.153900E-02 |
| N0-vs-N1 |
4.238400E-01 |
|
|
